Instrument Inactif

Autres langues Pharmagest Interactive LIQUIDNET SYSTEMS

Actions

FR0012882389

Services et conseils en informatique

Temps réel estimé Tradegate Autres places de cotation 17:19:01 04/08/2026			Varia. 5j.	Varia. 1 janv.
33,05 ^EUR	-48,36 %		0,00 %	-

31/07	Bourse : Thales et Exail publient les bans, Amazon et Sony brillent
31/07	Les haussiers se rebellent

Autres langues

30/07	Strong H1 2026 business performance: H1 revenue of €124.5 million (+7.3% on a reported basis) and ARR of €111.1 million at 30 June 2026 (+8.8% vs. 30 June 2025)
30/07	Equasens Société anonyme Reports Group Revenue Results for the Second Quarter and First Half Ended 30 June 2026
02/07	Equasens : RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2026
02/07	RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2026
02/07	Equasens Société Anonyme Announces Board Changes
26/06	Equasens Names Former CEO as New Chairman
25/06	Equasens renews its governance with the appointment of Dominique Pautrat as Chairman of the Board and four new directors
25/06	Equasens Group Announces Board Changes
10/06	ANNUAL ORDINARY GENERAL MEETING: MEETING NOTICE - ONLINE AVAILABILITY OF MEETING MATERIALS - WEBCAST LIVE
30/04	French and Benelux stocks-Factors to watch
30/04	Equasens Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025
29/04	Equasens Q1 revenue at 61.4 million euros
29/04	Solid Q1 2026 performance: revenue of €61.4 million (+7.7% reported)
29/04	Equasens Société anonyme Reports Revenue Results for the First Quarter Ended 31 March 2026
30/03	Equasens Société Anonyme Proposes the Payment of A Gross Dividend for the Year Ended 31 December 2025
30/03	Equasens Société Anonyme Announces Expiration of the Term of Office of Thierry Chapusot, Chairman of the Board of Directors and Founder, At the AGM on June 25, 2026
30/03	2025 annual results: Equasens reports a solid performance across all financial indicators
05/02	Equasens FY revenue at EUR 236.5 million
05/02	Strong commercial performance in 2025: Annual Recurring Revenue (ARR) of €108.0m (+8.8% as reported on 31 December 2025) and full-year revenue of €236.5m (+9.1% as reported)
05/01	Equasens Société anonyme agreed to acquire 80% stake in SAS Erevo.
05/01	Equasens to Buy Majority Stake in Digital Training Company Erevo
05/01	Equasens buys 80% stake in digital training company Erevo
05/01	EQUASENS ACCELERATES ITS DIGITAL TRAINING STRATEGY FOR HEALTHCARE PROFESSIONALS WITH THE ACQUISITION OF EREVO, A LEADING PURE-PLAY E-LEARNING PROVIDER
10/12	EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR
06/11	Equasens surges after 9m trading update